These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 38277031

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of Bisphosphonates on Osteoporosis Induced by Duchenne Muscular Dystrophy: A Prospective Study.
    Zheng WB, Dai Y, Hu J, Zhao DC, Wang O, Jiang Y, Xia WB, Xing XP, Li M.
    Endocr Pract; 2020 Dec; 26(12):1477-1485. PubMed ID: 33471740
    [Abstract] [Full Text] [Related]

  • 23. Bone mineral density and bone metabolism in Duchenne muscular dystrophy.
    Bianchi ML, Mazzanti A, Galbiati E, Saraifoger S, Dubini A, Cornelio F, Morandi L.
    Osteoporos Int; 2003 Sep; 14(9):761-7. PubMed ID: 12897980
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy.
    Söderpalm AC, Magnusson P, Ahlander AC, Karlsson J, Kroksmark AK, Tulinius M, Swolin-Eide D.
    Neuromuscul Disord; 2007 Dec; 17(11-12):919-28. PubMed ID: 17627820
    [Abstract] [Full Text] [Related]

  • 26. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests.
    Miller NF, Alfano LN, Iammarino MA, Connolly AM, Moore-Clingenpeel M, Powers BR, Tsao CY, Waldrop MA, Flanigan KM, Mendell JR, Lowes LP.
    Pediatr Neurol; 2020 Dec; 113():15-20. PubMed ID: 32979653
    [Abstract] [Full Text] [Related]

  • 27. Bone microarchitectural alterations in boys with Duchenne muscular dystrophy on long-term glucocorticoid treatment.
    Tung JY, Lam TP, Chan SH.
    J Bone Miner Metab; 2021 Jul; 39(4):606-611. PubMed ID: 33400004
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Bone density and alendronate effects in Duchenne muscular dystrophy patients.
    Houston C, Mathews K, Shibli-Rahhal A.
    Muscle Nerve; 2014 Apr; 49(4):506-11. PubMed ID: 23835890
    [Abstract] [Full Text] [Related]

  • 31. Fractures and bone health monitoring in boys with Duchenne muscular dystrophy managed within the Scottish Muscle Network.
    Joseph S, Wang C, Di Marco M, Horrocks I, Abu-Arafeh I, Baxter A, Cordeiro N, McLellan L, McWilliam K, Naismith K, Stephen E, Ahmed SF, Wong SC.
    Neuromuscul Disord; 2019 Jan; 29(1):59-66. PubMed ID: 30473133
    [Abstract] [Full Text] [Related]

  • 32. Factors Associated With Early Motor Function Trajectories in DMD After Glucocorticoid Initiation: Post Hoc Analysis of the FOR-DMD Trial.
    Schiava M, McDermott MP, Broomfield J, Abrams KR, Mayhew AG, McDonald CM, Martens WB, Gregory SJ, Griggs RC, Guglieri M, FOR-DMD investigators of the Muscle Study GroupFrom the John Walton Muscular Dystrophy Research Centre (M.S., A.G.M., M.G.), Clinical and Translational Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trusts, United Kingdom; Department of Biostatistics and Computational Biology (M.P.M.); Department of Neurology, University of Rochester Medical Centre, NY; Department of Health Sciences (J.B., K.R.A.), University of Leicester, United Kingdom; Department of Physical Medicine and Rehabilitation (C.M.M.), University of California, Davis, Sacramento; and Department of Neurology (W.B.M., S.J.G., R.C.G.), University of Rochester Medical Centre, NY..
    Neurology; 2024 May 28; 102(10):e209206. PubMed ID: 38710006
    [Abstract] [Full Text] [Related]

  • 33. Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment.
    Wong BL, Rybalsky I, Shellenbarger KC, Tian C, McMahon MA, Rutter MM, Sawnani H, Jefferies JL.
    J Pediatr; 2017 Mar 28; 182():296-303.e1. PubMed ID: 28043681
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of Denosumab for Glucocorticoid-Induced Osteoporosis in an Adolescent Patient with Duchenne Muscular Dystrophy: A Case Report.
    Kumaki D, Nakamura Y, Sakai N, Kosho T, Nakamura A, Hirabayashi S, Suzuki T, Kamimura M, Kato H.
    JBJS Case Connect; 2018 Mar 28; 8(2):e22. PubMed ID: 29642113
    [Abstract] [Full Text] [Related]

  • 35. Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study.
    Majumdar SR, Morin SN, Lix LM, Leslie WD.
    Osteoporos Int; 2013 Sep 28; 24(9):2493-8. PubMed ID: 23572142
    [Abstract] [Full Text] [Related]

  • 36. The effect of oral bisphosphonate therapy on vertebral morphometry and fractures in patients with Duchenne muscular dystrophy and glucocorticoid-induced osteoporosis.
    Nasomyont N, Tian C, Hornung L, Khoury J, Hochwalt PM, Tilden JC, Wong BL, Rutter MM.
    Muscle Nerve; 2021 Dec 28; 64(6):710-716. PubMed ID: 34506040
    [Abstract] [Full Text] [Related]

  • 37. Evaluating RANKL and OPG levels in patients with Duchenne muscular dystrophy.
    Akhtar Ali S, Kang H, Olney R, Ramos-Platt L, Ryabets-Lienhard A, Cheung C, Georgia S, Pitukcheewanont P.
    Osteoporos Int; 2019 Nov 28; 30(11):2283-2288. PubMed ID: 31392399
    [Abstract] [Full Text] [Related]

  • 38. Bone Health and Endocrine Care of Boys with Duchenne Muscular Dystrophy: Data from the MD STARnet.
    Weber DR, Thomas S, Erickson SW, Fox D, Oleszek J, Pandya S, Venkatesh Y, Westfield C, Ciafaloni E, Muscular Dystrophy Tracking and Research Network (MD STAR.
    J Neuromuscul Dis; 2018 Nov 28; 5(4):497-507. PubMed ID: 30149461
    [Abstract] [Full Text] [Related]

  • 39. Use of bone age for evaluating bone density in patients with Duchenne muscular dystrophy: A preliminary report.
    Al-Zougbi A, Mathews KD, Shibli-Rahhal A.
    Muscle Nerve; 2019 Apr 28; 59(4):422-425. PubMed ID: 30636004
    [Abstract] [Full Text] [Related]

  • 40. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
    Segaud N, Legroux I, Hazzan M, Noel C, Cortet B.
    Osteoporos Int; 2018 May 28; 29(5):1165-1175. PubMed ID: 29500526
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.